Results 131 to 140 of about 41,188 (289)
Coexistence of myeloproliferative neoplasms with multiple myeloma
Qiuqing Xiang +8 more
openalex +1 more source
What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog
Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson +5 more
wiley +1 more source
What Is Your Diagnosis? Multiple Subcutaneous Lumps in a Horse
Veterinary Clinical Pathology, EarlyView.
Federica Meistro +4 more
wiley +1 more source
ABSTRACT Monocytes are key components of the Mononuclear Phagocyte System, crucial in immune defense, inflammation, and tissue repair. Accurate identification and classification of monocyte lineage cells are essential for diagnosing both reactive and clonal hematologic disorders.
Gina Zini +10 more
wiley +1 more source
Is Myeloproliferative Neoplasm with Splanchnic Vein Thrombosis a Distinct Clinical Entity? [PDF]
Clinical History: A 29 year-old previously healthy female presented with sub-acute symptoms of weight loss, right upper quadrant pain and nausea. CBC results: WBC-11.7, Hb- 12.5, Platelet- 286, MCV- 90, MCV- 26.8, RDW- 18%.
Gong, MD, Jerald Z. +2 more
core +1 more source
Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases
ABSTRACT Ischemic stroke is a rare complication of hypereosinophilic syndrome (HES). Manifestations of stroke in HES have been described in the radiologic literature; however the pathologic characterization of central nervous system (CNS) involvement in HES is limited.
Karina C. Martin +3 more
wiley +1 more source
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes [PDF]
Caroline McNamara +23 more
openalex +1 more source
Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms [PDF]
Laura Palomo +2 more
openalex +1 more source
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner +7 more
wiley +1 more source

